Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03071250 · ClinicalTrials.gov registry record

An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty

A clinical trial, sponsored by University of Arkansas.

Completed
Registry status
500
Enrollment target

NCT03071250: Completed study, sponsored by University of Arkansas.

NCT03071250 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03071250 has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

The care for patients receiving total hip and knee arthroplasty at the University of Arkansas for Medical Sciences has followed a structured care pathway since July 2015. This system of perioperative care has focused on preoperative assessment of medical co-morbidities and risks to postoperative functional recovery, anesthetic care focused on postoperative nausea and vomiting prevention and optimizing immediate postoperative functional ability, and aggressive postoperative physical therapy. This is an observational study to look at the outcomes of this program at University of Arkansas for Medical Sciences. Areas of focus will be hospital length of stay, postoperative narcotic consumption, Visual Analog Scale scores, incidence of postoperative nausea and vomiting, and 30-day readmission rates, and health literacy rates.

Primary Outcome

Postoperative hospital length of stay

Interventions

  • PROCEDURE Total knee or Hip Arthroplasty

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2018-10-01
Est. Completion 2019-07-01
University of Arkansas

318 total trials

What the finished NCT03071250 record still lists

NCT03071250 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Total knee or Hip Arthroplasty is the first listed.

NCT03071250 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03071250 about?

NCT03071250 is a clinical study titled "An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty". The care for patients receiving total hip and knee arthroplasty at the University of Arkansas for Medical Sciences has followed a structured care pathway since July 2015. This system of perioperative care has focused on preoperative assessment of medical co-morbidities and risks to postoperative fun...

What is the current status of trial NCT03071250?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2018-10-01. Estimated completion is 2019-07-01.

What interventions are being tested in trial NCT03071250?

The interventions under investigation include: Total knee or Hip Arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT03071250?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03071250, the US trial registry maintained by the National Library of Medicine. NCT03071250 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.